CEL-SCI Corporation (CVM)
AMEX·Healthcare·Biotechnology
$3.10
-4.91%
Mkt Cap $26.59M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | — | — | — | — | -$0.68 | — | — | — |
| Q1 2026 Jan 12, 2026 | — | — | — | — | -$2.70 | — | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | — | -$1.36 | — | — | — |
| Q2 2025 May 14, 2025 | — | — | — | — | -$2.40 | — | — | — |
| Q1 2025 Feb 14, 2025 | — | — | — | — | -$3.30 | — | — | — |
| Q1 2025 Jan 13, 2025 | — | $5.95M | — | -$3.00 | -$2.70 | +10.00% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$3.60 | -$4.20 | -16.67% | — | — |
| Q2 2024 May 16, 2024 | — | — | — | -$3.90 | -$4.20 | -7.69% | — | — |
| Q1 2024 Feb 14, 2024 | — | — | — | -$4.20 | -$4.20 | +0.00% | — | — |
| Q4 2023 Dec 22, 2023 | — | — | — | -$4.20 | -$4.80 | -14.29% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$4.50 | -$5.71 | -26.89% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$0.17 | -$5.71 | -3258.82% | — | — |
| Q1 2023 Feb 14, 2023 | — | — | — | -$0.16 | -$5.41 | -3281.25% | — | — |
| Q4 2022 Dec 28, 2022 | — | — | — | -$0.15 | -$6.31 | -4106.67% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.15 | -$6.91 | -4506.67% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.15 | -$6.91 | -4358.06% | — | — |
| Q1 2022 Feb 14, 2022 | $100.00K | — | — | — | -$6.01 | — | — | — |
| Q4 2021 Dec 22, 2021 | $100.00K | — | — | -$3.00 | -$5.71 | -90.33% | — | — |
| Q3 2021 Aug 16, 2021 | $100.00K | — | — | -$3.90 | -$7.51 | -92.56% | — | — |
| Q2 2021 May 18, 2021 | — | — | — | -$5.71 | -$6.01 | -5.25% | — | — |